NyquistAI announced that the FDA released three new regulatory guidances released more than 20 years ago.
Published
Signal category
Legal & Regulatory
Quote
“Today, September 2, 2026, #FDA released three new guidances.”
— NyquistAI team
Company
NyquistAI
One AI platform for the world’s data, insight, and market intelligence to power life sciences innovation
- Industry
- Software Development
- Location
- Palo Alto, US
- Company size
- 11 employees
NyquistAI is the one AI life sciences platform for global data, insight and intelligence. Based in the heart of Silicon Valley and graduated from the prestigious Google Accelerator, NyquistAI aggregates and synthesizes planet-scale data to enable you to distill and digest decades of information in seconds to discover insights you didn’t and couldn’t know existed and uncover opportunities that were previously out of reach. The clarity and speed provided by having only the most relevant, accurate, and most up-to-date information and knowledge at your fingertips empower transformative decision-making that accelerates your speed to market. We are trusted by CXOs of the top 50 pharma, Medtech, and CROs such as Medtronic, Astellas, and NAMSA. Visit us at www.nyquistai.com to book a demo to learn how the latest AI technology and transform your innovation today and into the future.
Founded 2020